View on Pubmed.gov 29081665 | View on doi.org 10.2147/OTT.S14...
Clinical significance of , epithelial-mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients.
- Department of General Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine.
- Department of General Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital.
- Department of General Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine. Central Laboratory, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, South Campus, Shanghai, China.
Abstract
Colorectal cancer (CRC) is a common digestive malignancy and emerging studies have closely linked its initiation and development with gut microbiota changes. () has been recently identified as a pathogenic bacteria for CRC; however, its prognostic significance for patients is poorly investigated and is less for patients within late stage. Therefore, in this study, we made efforts to analyze its level and prognostic significance in a retrospective cohort of 280 stage III/IV CRC patients. We found that the level was abnormally high in tumor tissues and correlated with tumor invasion, lymph node metastasis status, and distant metastasis. We also identified it as an independent adverse prognostic factor for cancer-specific survival (CSS) and disease-free survival (DFS). The following subgroup analysis indicated that level could stratify CSS and DFS in stage IIIB/C and IV patients but failed in stage IIIA patients. In addition, stage III/IV patients with low level were found to benefit more from adjuvant chemotherapy than those with high level, in terms of DFS. Finally, we analyzed the expression and clinical significance of epithelial-to-mesenchymal transition (EMT) markers (E-cadherin and N-cadherin) and cancer stem cell (CSC) markers (Nanog, Oct-4, and Sox-2) in CRC tissues. The results indicated that N-cadherin, Nanog, Oct-4, and Sox-2 were adverse prognostic factors in these patients, while the opposite was true for E-cadherin. More importantly, expression of E-cadherin, N-cadherin, and Nanog was significantly correlated with level in tumor tissues, suggesting the potential involvement of in EMT-CSC cross talk during CRC progression. Taken together, these findings indicate that is a novel predictive biomarker for clinical management in stage III/IV patients, and targeting may be an effective adjuvant approach for preventing CRC metastasis and chemotherapy resistance.
References
Am J Cancer Res. 2016 Oct 01;6(10 ):2323-2333
ESMO Open. 2016 Sep 16;1(5):e000088
PLoS One. 2015 Mar 25;10 (3):e0120050
CA Cancer J Clin. 2017 May 6;67(3):177-193
Cited by 95 citations (total)
Journal Article Review
Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer.
Electronic publication date December 18, 2019
Yang Liu [...] Hideo Baba et al.
Microbiome research is a rapidly advancing field in human cancers. Fusobacterium nucleatum is an oral bacterium, indigenous to the human...
Journal Article Review
Fusobacterium nucleatum and oral cancer: a critical review.
Electronic publication date February 19, 2022
Emily McIlvanna [...] Jacqueline A James et al.
There is a growing level of interest in the potential role inflammation has on the initiation and progression of malignancy....
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •